These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34646012)

  • 1. Structural basis of cytokine-mediated activation of ALK family receptors.
    De Munck S; Provost M; Kurikawa M; Omori I; Mukohyama J; Felix J; Bloch Y; Abdel-Wahab O; Bazan JF; Yoshimi A; Savvides SN
    Nature; 2021 Dec; 600(7887):143-147. PubMed ID: 34646012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism for the activation of the anaplastic lymphoma kinase receptor.
    Reshetnyak AV; Rossi P; Myasnikov AG; Sowaileh M; Mohanty J; Nourse A; Miller DJ; Lax I; Schlessinger J; Kalodimos CG
    Nature; 2021 Dec; 600(7887):153-157. PubMed ID: 34819673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
    Reshetnyak AV; Murray PB; Shi X; Mo ES; Mohanty J; Tome F; Bai H; Gunel M; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15862-7. PubMed ID: 26630010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
    Katic L; Priscan A
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for ligand reception by anaplastic lymphoma kinase.
    Li T; Stayrook SE; Tsutsui Y; Zhang J; Wang Y; Li H; Proffitt A; Krimmer SG; Ahmed M; Belliveau O; Walker IX; Mudumbi KC; Suzuki Y; Lax I; Alvarado D; Lemmon MA; Schlessinger J; Klein DE
    Nature; 2021 Dec; 600(7887):148-152. PubMed ID: 34819665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
    Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
    Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).
    Reshetnyak AV; Mohanty J; Tomé F; Puleo DE; Plotnikov AN; Ahmed M; Kaur N; Poliakov A; Cinnaiyan AM; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8340-8345. PubMed ID: 30061385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypothalamic pathway for Augmentor α-controlled body weight regulation.
    Ahmed M; Kaur N; Cheng Q; Shanabrough M; Tretiakov EO; Harkany T; Horvath TL; Schlessinger J
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2200476119. PubMed ID: 35412887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells.
    Fadeev A; Mendoza-Garcia P; Irion U; Guan J; Pfeifer K; Wiessner S; Serluca F; Singh AP; Nüsslein-Volhard C; Palmer RH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E630-E638. PubMed ID: 29317532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk.
    Mo ES; Cheng Q; Reshetnyak AV; Schlessinger J; Nicoli S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12027-12032. PubMed ID: 29078341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.
    Murray PB; Lax I; Reshetnyak A; Ligon GF; Lillquist JS; Natoli EJ; Shi X; Folta-Stogniew E; Gunel M; Alvarado D; Schlessinger J
    Sci Signal; 2015 Jan; 8(360):ra6. PubMed ID: 25605972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome.
    Zhang H; Pao LI; Zhou A; Brace AD; Halenbeck R; Hsu AW; Bray TL; Hestir K; Bosch E; Lee E; Wang G; Liu H; Wong BR; Kavanaugh WM; Williams LT
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15741-5. PubMed ID: 25331893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements.
    Javanmardi N; Fransson S; Djos A; Umapathy G; Östensson M; Milosevic J; Borenäs M; Hallberg B; Kogner P; Martinsson T; Palmer RH
    Genes Chromosomes Cancer; 2020 Jan; 59(1):50-57. PubMed ID: 31340081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration.
    Huang H; Gont A; Kee L; Dries R; Pfeifer K; Sharma B; Debruyne DN; Harlow M; Sengupta S; Guan J; Yeung CM; Wang W; Hallberg B; Palmer RH; Irwin MS; George RE
    Cell Rep; 2021 Jul; 36(2):109363. PubMed ID: 34260934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK-activating homologous mutations in LTK induce cellular transformation.
    Roll JD; Reuther GW
    PLoS One; 2012; 7(2):e31733. PubMed ID: 22347506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Transition of Key Structural Features Involved in Activation of ALK Induced by Two Neuroblastoma Mutations and ATP Binding: Insight from Accelerated Molecular Dynamics Simulations.
    He MY; Li WK; Zheng QC; Zhang HX
    ACS Chem Neurosci; 2018 Jul; 9(7):1783-1792. PubMed ID: 29638111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
    Deuel TF
    Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain.
    Defaye M; Iftinca MC; Gadotti VM; Basso L; Abdullah NS; Cuménal M; Agosti F; Hassan A; Flynn R; Martin J; Soubeyre V; Poulen G; Lonjon N; Vachiery-Lahaye F; Bauchet L; Mery PF; Bourinet E; Zamponi GW; Altier C
    J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35608912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
    Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
    J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.